Heart/Lung: Recipients: Immunosuppression Use


View HTML View PDF
13.6aImmunosuppression Use for Induction, 1995 to 2004 Recipients with Heart-Lung TransplantsTable 13.6a (30 k)
13.6bImmunosuppression Use for Induction by Discharge Regimen, 2000 to 2004 Recipients with Heart-Lung TransplantsTable 13.6b (32 k)
13.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2000 to 2004 Recipients with Heart-Lung TransplantsTable 13.6c (29 k)
13.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1995 to 2004 Recipients with Heart-Lung TransplantsTable 13.6d (30 k)
13.6eImmunosuppression Use for Maintenance Prior to Discharge, 1995 to 2004 Recipients with Heart-Lung TransplantsTable 13.6e (31 k)
13.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1994 to 2003 Recipients with Heart-Lung TransplantsTable 13.6f (31 k)
13.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1994 to 2003 Recipients with Heart-Lung TransplantsTable 13.6g (31 k)
13.6hPersistency of Discharge Regimen by Follow-up Period, 1999 to 2003 Recipients with Heart-Lung TransplantsTable 13.6h (30 k)
13.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1994 to 2003 Recipients with Heart-Lung TransplantsTable 13.6i (30 k)
15.15Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2002 Recipients with Heart-Lung TransplantsTable 15.15 (31 k)